Assessing target engagement using proteome-wide solvent shift assays
Published version of a preprint
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Recent advances in mass spectrometry (MS) have enabled quantitative proteomics to become a powerful tool in the field of drug discovery, especially when applied toward proteome-wide target engagement studies. Similar to temperature gradients, increasing concentrations of organic solvents stimulate unfolding and precipitation of the cellular proteome. This property can be influenced by physical association with ligands and other molecules, making individual proteins more or less susceptible to solvent-induced denaturation. Herein, we report the development of proteome-wide solvent shift assays by combining the principles of solvent-induced precipitation (Zhang et al., 2020) with modern quantitative proteomics. Using this approach, we developed solvent proteome profiling (SPP), which is capable of establishing target engagement through analysis of SPP denaturation curves. We readily identified the specific targets of compounds with known mechanisms of action. As a further efficiency boost, we applied the concept of area under the curve analysis to develop solvent proteome integral solubility alteration (solvent-PISA) and demonstrate that this approach can serve as a reliable surrogate for SPP. We propose that by combining SPP with alternative methods, like thermal proteome profiling, it will be possible to increase the absolute number of high-quality melting curves that are attainable by either approach individually, thereby increasing the fraction of the proteome that can be screened for evidence of ligand binding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In general, PISA experiments measure changes in protein precipitation that can be induced by altering temperature (70), solvent concentration (67), mechanical stress (73), or ion concentration (74).”
From Assessing Target Specificity of the Small Molecule Inhibitor MARIMASTAT to Snake Venom Toxins: A Novel Application of Thermal Proteome Profiling (2024) · cites this paper as [67]
In the citing paper
“Traditional TPP assays were centered on the principle that unbound proteins tend to denature and become insoluble when subjected to increasing temperatures, whereas proteins stabilized through interactions with extrinsic factors often exhibit increased thermal stability and remain in solution (65, 67, 68, 69).”
From Assessing Target Specificity of the Small Molecule Inhibitor MARIMASTAT to Snake Venom Toxins: A Novel Application of Thermal Proteome Profiling (2024) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Elias, J. E., & Gygi, S. P. (2007) · Nature Methods · doi:10.1038/nmeth1019 · Cited by 3,925
Self-citationMonitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261 · cited 2×
“So, while proteome-wide solvent and thermal shift assays behave comparably in lysate-based experiments, SPP and solvent-PISA are not amenable to cell-based approaches, like CETSA (Jafari et al., 2014; Molina et al., 2013).”
MethodA tissue-specific atlas of mouse protein phosphorylation and expression
Huttlin, E. L., Jedrychowski, M. P., Elias, J. E., Goswami, T., Rad, R., Beausoleil, S. A., Villén, J., Haas, W., Sowa, M. E., & Gygi, S. P. (2010) · Cell · doi:10.1016/j.cell.2010.12.001 · Cited by 1,778 · cited 2×
“PSM filtering was performed using linear discriminant analysis (LDA) as described previously (Huttlin et al., 2010), while considering the following parameters: comet log expect, different sequence delta comet log expect (percent difference between the first hit and the next hit with a different…”
MethodSelf-citationTracking cancer drugs in living cells by thermal profiling of the proteome
Savitski, M. M., Reinhard, F. B. M., Franken, H., Werner, T., Savitski, M. F., Eberhard, D., Molina, D. M., Jafari, R., Dovega, R. B., Klaeger, S., et al. (2014) · Science · doi:10.1126/science.1255784 · Cited by 1,187 · cited 5×
“70784 13 of 21 The solvent shift assays introduced here echo many important features of proteomewide thermal shift assays—TPP and thermalPISA (Gaetani et al., 2019; Savitski et al., 2014).”
BackgroundMethodInfluentialProteome Integral Solubility Alteration: A High-Throughput Proteomics Assay for Target Deconvolution
Gaetani, M., Sabatier, P., Saei, A. A., Beusch, C. M., Yang, Z., Lundström, S. L., & Zubarev, R. A. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00500 · Cited by 287 · cited 4×
“Recently, the proteome integral solubility alteration (PISA) assay was proposed to improve the efficiency of proteomewide thermal shift assays (Gaetani et al., 2019).”
BackgroundMethodInfluentialThermal proteome profiling for interrogating protein interactions
Mateus, A., Kurzawa, N., Becher, I., Sridharan, S., Helm, D., Stein, F., Typas, A., & Savitski, M. M. (2020) · Molecular Systems Biology · doi:10.15252/msb.20199232 · Cited by 258
Schweppe, D. K., Prasad, S., Belford, M. W., Navarrete-Perea, J., Bailey, D. J., Huguet, R., Jedrychowski, M. P., Rad, R., McAlister, G., Abbatiello, S. E., et al. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.8b05399 · Cited by 229
Self-citationThompson, A., Wölmer, N., Koncarevic, S., Selzer, S., Böhm, G., Legner, H., Schmid, P., Kienle, S., Penning, P., Höhle, C., et al. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b04474 · Cited by 186 · cited 6×
“In the end, 12 of 24 fractions were analyzed by LC-MS/MS. Mass spectrometry data acquisition Data were collected on an Orbitrap Eclipse mass spectrometer (ThermoFisher Scientific) coupled to a Proxeon EASY-nLC 1000 LC pump (ThermoFisher Scientific).”
MethodInfluentialHow Chemoproteomics Can Enable Drug Discovery and Development
Moellering, R. E., & Cravatt, B. F. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.01.001 · Cited by 182
Identifying drug targets in tissues and whole blood with thermal-shift profiling
Perrin, J., Werner, T., Kurzawa, N., Rutkowska, A., Childs, D. D., Kalxdorf, M., Poeckel, D., Stonehouse, E., Strohmer, K., Heller, B., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0388-4 · Cited by 178 · cited 2×
“While TPP and CETSA have proven to be gamechangers in the field of chemo- proteomics and have spawned numerous variations (Ball et al., 2020; Mateus et al., 2020; Perrin et al., 2020; Saei et al., 2021), the assays are not without their drawbacks.”
BackgroundImproved Proteomics-Based Drug Mechanism-of-Action Studies Using 16-Plex Isobaric Mass Tags
Zinn, N., Werner, T., Doce, C., Mathieson, T., Boecker, C., Sweetman, G., Fufezan, C., & Bantscheff, M. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00900 · Cited by 49
Research works printed but not linked: 33
- Ball, 2020, An isothermal shift assay for proteome scale drug-target identification, Communications Biology, 3, 10.1038/s42003-020-0795-6 · DOI
- Bavetsias, 2015, Aurora Kinase Inhibitors: Current Status and Outlook, Frontiers in Oncology, 5, 10.3389/fonc.2015.00278 · DOI · Paper page
- Becher, 2018, Pervasive Protein Thermal Stability Variation during the Cell Cycle, Cell, 173, 1495, 10.1016/j.cell.2018.03.053 · DOI · Paper page
- Chan, 1986, The kinetics of protein precipitation by different reagents, Biotechnology and Bioengineering, 28, 387, 10.1002/bit.260280312 · DOI
- Childs, 2019, Nonparametric Analysis of Thermal Proteome Profiles Reveals Novel Drug-binding Proteins, Molecular & Cellular Proteomics, 18, 2506, 10.1074/mcp.TIR119.001481 · DOI · Paper page
- Cousins, 2018, Competitive Kinase Enrichment Proteomics Reveals that Abemaciclib Inhibits GSK3β and Activates WNT Signaling, Molecular Cancer Research, 16, 333, 10.1158/1541-7786.MCR-17-0468 · DOI
- Dai, 2018, Modulation of Protein-Interaction States through the Cell Cycle, Cell, 173, 1481, 10.1016/j.cell.2018.03.065 · DOI · Paper page
- Daub, 2015, Quantitative proteomics of kinase inhibitor targets and mechanisms, ACS Chemical Biology, 10, 201, 10.1021/cb5008794 · DOI
- Dominguez, 2005, p38 MAP kinase inhibitors: Many are made, but few are chosen, Current Opinion in Drug Discovery & Development, 8, 421
- Franken, 2015, Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry, Nature Protocols, 10, 1567, 10.1038/nprot.2015.101 · DOI · Paper page
- Frantzi, 2019, Proteomics in Drug Development: The Dawn of a New Era?, PROTEOMICS – Clinical Applications, 13, 10.1002/prca.201800087 · DOI
- Hideshima, 2004, p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells, Oncogene, 23, 8766, 10.1038/sj.onc.1208118 · DOI
- Hirai, 2010, MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo, Molecular Cancer Therapeutics, 9, 1956, 10.1158/1535-7163.MCT-09-1012 · DOI · Paper page
- Huang, 2009, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, Nature Protocols, 4, 44, 10.1038/nprot.2008.211 · DOI · Paper page
- Hughes, 2014, Ultrasensitive proteome analysis using paramagnetic bead technology, Molecular Systems Biology, 10, 10.15252/msb.20145625 · DOI · Paper page
- Hughes, 2019, Single-pot, solid-phase-enhanced sample preparation for proteomics experiments, Nature Protocols, 14, 68, 10.1038/s41596-018-0082-x · DOI · Paper page
- Jafari, 2014, The cellular thermal shift assay for evaluating drug target interactions in cells, Nature Protocols, 9, 2100, 10.1038/nprot.2014.138 · DOI · Paper page
- Jarzab, 2020, Meltome atlas-thermal proteome stability across the tree of life, Nature Methods, 17, 495, 10.1038/s41592-020-0801-4 · DOI · Paper page
- Li, 2020, Selection of Heating Temperatures Improves the Sensitivity of the Proteome Integral Solubility Alteration Assay, Journal of Proteome Research, 19, 2159, 10.1021/acs.jproteome.0c00063 · DOI · Paper page
- Li, 2020, TMTpro reagents: a set of isobaric labeling mass tags enables simultaneous proteome-wide measurements across 16 samples, Nature Methods, 17, 399, 10.1038/s41592-020-0781-4 · DOI · Paper page
- Marks, 2007, Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug, Nature Biotechnology, 25, 84, 10.1038/nbt1272 · DOI · Paper page
- Meng, 2018, Chemical Denaturation and Protein Precipitation Approach for Discovery and Quantitation of Protein-Drug Interactions, Analytical Chemistry, 90, 9249, 10.1021/acs.analchem.8b01772 · DOI
- Rad, 2021, Improved Monoisotopic Mass Estimation for Deeper Proteome Coverage, Journal of Proteome Research, 20, 591, 10.1021/acs.jproteome.0c00563 · DOI · Paper page
- Reinhard, 2015, Thermal proteome profiling monitors ligand interactions with cellular membrane proteins, Nature Methods, 12, 1129, 10.1038/nmeth.3652 · DOI · Paper page
- Robers, 2020, Quantifying Target Occupancy of Small Molecules Within Living Cells, Annual Review of Biochemistry, 89, 557, 10.1146/annurev-biochem-011420-092302 · DOI
- Saei, 2021, System-wide identification and prioritization of enzyme substrates by thermal analysis, Nature Communications, 12, 10.1038/s41467-021-21540-6 · DOI
- Savitski, 2015, A Scalable Approach for Protein False Discovery Rate Estimation in Large Proteomic Data Sets, Molecular & Cellular Proteomics, 14, 2394, 10.1074/mcp.M114.046995 · DOI · Paper page
- Schürmann, 2016, Small-Molecule Target Engagement in Cells, Cell Chemical Biology, 23, 435, 10.1016/j.chembiol.2016.03.008 · DOI
- Shih, 1992, Some characteristics of protein precipitation by salts, Biotechnology and Bioengineering, 40, 1155, 10.1002/bit.260401004 · doi:10.1002/bit.260401004
- Sridharan, 2019, Proteome-wide solubility and thermal stability profiling reveals distinct regulatory roles for ATP, Nature Communications, 10, 10.1038/s41467-019-09107-y · DOI · Paper page
- Tyanova, 2016, The Perseus computational platform for comprehensive analysis of (prote)omics data, Nature Methods, 13, 731, 10.1038/nmeth.3901 · DOI · Paper page
- Wingfield, 2001, Protein precipitation using ammonium sulfate, Current Protocols in Protein Science, 3, 10.1002/0471140864.psa03fs13 · DOI · Paper page
- Zhang, 2020, Solvent-Induced Protein Precipitation for Drug Target Discovery on the Proteomic Scale, Analytical Chemistry, 92, 1363, 10.1021/acs.analchem.9b04531 · DOI · Paper page
Cited by
Mega-scale experimental analysis of protein folding stability in biology and protein design
Tsuboyama, K., Dauparas, J., Chen, J., Laine, E., Mohseni Behbahani, Y., Weinstein, J. J., Mangan, N. M., Ovchinnikov, S., & Rocklin, G. J. (2022) · doi:10.1101/2022.12.06.519132 · Cited by 352
Mega-scale experimental analysis of protein folding stability in biology and design
Tsuboyama, K., Dauparas, J., Chen, J., Laine, E., Mohseni Behbahani, Y., Weinstein, J. J., Mangan, N. M., Ovchinnikov, S., & Rocklin, G. J. (2023) · Nature · doi:10.1038/s41586-023-06328-6 · Cited by 350
High-throughput identification of calcium-regulated proteins across diverse proteomes
Locke, T. M., Fields, R., Gizinski, H., Otto, G. M., MacEwen, M. J. S., Rusnac, D.-V., He, P., Shechner, D. M., McGann, C. D., Berg, M. D., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114879 · Cited by 17
Smith, C. F., Modahl, C. M., Ceja Galindo, D., Larson, K. Y., Maroney, S. P., Bahrabadi, L., Brandehoff, N. P., Perry, B. W., McCabe, M. C., Petras, D., et al. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100779 · Cited by 11
Metadata
- Authors
- Van Vranken, J. G., Li, J., Mitchell, D. C., Navarrete-Perea, J., & Gygi, S. P.
- Affiliations
- Department of Cell Biology, Harvard Medical School
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2021-12-08
- Volume
- 10
- ISSN
- 2050-084X
- Cited by
- 71
- References
- 11
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0/ (vor)
- creativecommons.org/licenses/by/4.0/ (am)
- creativecommons.org/licenses/by/4.0/ (tdm)
- Funders
- Damon Runyon Cancer Research Foundation (DRG-2359-19)
- Mark Foundation For Cancer Research (DRG-2359-19)
- National Institutes of Health (GM097645)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.